- Type / Class
- Equity / Common Stock
- Shares outstanding
- 61,152,075
- Total 13F shares
- 30,513,340
- Share change
- +1,197,005
- Total reported value
- $1,222,363,447
- Price per share
- $40.06
- Number of holders
- 64
- Value change
- +$50,139,269
- Number of buys
- 36
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
9.1%
|
5,580,690
|
$202,300,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
5.9%
|
3,630,224
|
$131,596,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
5.5%
|
3,367,315
|
$122,065,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.8%
|
2,348,840
|
$85,145,000 | — | 30 Sep 2017 | |
| EcoR1 Capital, LLC |
13F
|
Company |
3.4%
|
2,107,600
|
$76,401,000 | — | 30 Sep 2017 | |
| Vivo Capital, LLC |
13F
|
Company |
2.9%
|
1,766,832
|
$64,048,000 | — | 30 Sep 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.7%
|
1,636,124
|
$59,309,000 | — | 30 Sep 2017 | |
| VHCP Management II, LLC |
13F
|
Company |
2.1%
|
1,299,052
|
$47,091,000 | — | 30 Sep 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,204,540
|
$43,665,000 | — | 30 Sep 2017 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.4%
|
850,000
|
$30,813,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.84%
|
512,414
|
$18,575,000 | — | 30 Sep 2017 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.82%
|
500,000
|
$18,125,000 | — | 30 Sep 2017 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.74%
|
454,485
|
$16,361,000 | — | 30 Sep 2017 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.58%
|
355,348
|
$12,881,000 | — | 30 Sep 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.49%
|
297,360
|
$10,779,000 | — | 30 Sep 2017 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.47%
|
285,143
|
$10,336,000 | — | 30 Sep 2017 | |
| Laurion Capital Management LP |
13F
|
Company |
0.46%
|
283,330
|
$10,271,000 | — | 30 Sep 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.46%
|
280,000
|
$10,150,000 | — | 30 Sep 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.42%
|
258,653
|
$9,376,000 | — | 30 Sep 2017 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.33%
|
200,000
|
$7,250,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
201,781
|
$7,163,000 | — | 30 Sep 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.21%
|
129,474
|
$4,693,000 | — | 30 Sep 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.2%
|
120,450
|
$4,366,000 | — | 30 Sep 2017 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.2%
|
120,000
|
$4,350,000 | — | 30 Sep 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.18%
|
110,000
|
$3,988,000 | — | 30 Sep 2017 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
99,328
|
$3,601,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
92,680
|
$3,358,000 | — | 30 Sep 2017 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.12%
|
72,226
|
$2,618,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
67,332
|
$2,441,000 | — | 30 Sep 2017 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.1%
|
59,876
|
$2,171,000 | — | 30 Sep 2017 | |
| Magnetar Financial LLC |
13F
|
Company |
0.06%
|
38,985
|
$1,413,000 | — | 30 Sep 2017 | |
| HBK INVESTMENTS L P |
13F
|
Company |
0.06%
|
35,000
|
$1,269,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
33,500
|
$1,214,000 | — | 30 Sep 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
31,929
|
$1,157,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
30,076
|
$1,090,000 | — | 30 Sep 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
30,000
|
$1,088,000 | — | 30 Sep 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.05%
|
30,000
|
$1,088,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
19,972
|
$723,000 | — | 30 Sep 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
19,658
|
$713,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
18,752
|
$679,000 | — | 30 Sep 2017 | |
| Endurant Capital Management LP |
13F
|
Company |
0.03%
|
17,330
|
$628,000 | — | 30 Sep 2017 | |
| Maven Securities LTD |
13F
|
Company |
0.03%
|
16,757
|
$610,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
10,273
|
$372,000 | — | 30 Sep 2017 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
9,763
|
$354,000 | — | 30 Sep 2017 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
9,704
|
$352,000 | — | 30 Sep 2017 | |
| Trexquant Investment LP |
13F
|
Company |
0.01%
|
8,832
|
$320,000 | — | 30 Sep 2017 | |
| Matisse Capital |
13F
|
Company |
0.01%
|
8,590
|
$311,000 | — | 30 Sep 2017 | |
| Aperio Group, LLC |
13F
|
Company |
0.01%
|
6,659
|
$241,000 | — | 30 Sep 2017 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.01%
|
6,245
|
$226,000 | — | 30 Sep 2017 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.01%
|
5,918
|
$215,000 | — | 30 Sep 2017 |
Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q4 2017
As of 31 Dec 2017,
Ascendis Pharma A/S - Common Stock (ASND) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,513,340 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, Vivo Capital, LLC, venBio Select Advisor LLC, EVENTIDE ASSET MANAGEMENT, LLC, VHCP Management II, LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
59
Q4 2017 holders
64
Holder diff
5
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.